Ani Pharmaceuticals ANIP
NASDAQ ANIP
$72.18 -0.78 (-1.07%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ani Pharmaceuticals (ANIP) Liabilities from Discontinued Operations (2012 - 2013)

Updated

Ani Pharmaceuticals (ANIP) reported Liabilities from Discontinued Operations of $131,613 for Q3 2013, down 64.1% from the prior quarter.

Analysis

Ani Pharmaceuticals (ANIP) Liabilities from Discontinued Operations (2012 - 2013) Analysis & Trends

At the end of FY2012, Ani Pharmaceuticals posted Liabilities from Discontinued Operations of $370,766.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Ani Pharmaceuticals 1.74 Bn 520.73 Mn 165.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2013 131,613.00
Jun 30, 2013 366,390.00
Dec 31, 2012 370,766.00
API Access

Ani Pharmaceuticals Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=ANIP&period=max&api_key=YOUR_API_KEY